Premium
CB 2 receptor‐mediated migration of immune cells: it can go either way
Author(s) -
Miller A M,
Stella N
Publication year - 2008
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0707523
Subject(s) - inflammation , immune system , receptor , agonist , immunology , neuroscience , medicine , pharmacology , biology
Though many studies have examined the role of CB 2 receptors in immune cell migration, it has been difficult to form definitive conclusions about the physiopathological role of these receptors in regulating immune responses and how this might be pharmacologically targeted for therapy. Do cannabinoids promote inflammation through the recruitment of immune cells, or reduce inflammation by interfering with the action of other chemoattractants? Is therapeutic intervention with an agonist or antagonist more appropriate for the reduction of inflammation? In this review, we will summarize the progress that has been made in answering these questions and outline current hypotheses. British Journal of Pharmacology (2008) 153 , 299–308; doi: 10.1038/sj.bjp.0707523 ; published online 5 November 2007